0001618835-19-000138.txt : 20190701 0001618835-19-000138.hdr.sgml : 20190701 20190701144235 ACCESSION NUMBER: 0001618835-19-000138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190701 DATE AS OF CHANGE: 20190701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Thomas G CENTRAL INDEX KEY: 0001360000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36754 FILM NUMBER: 19932764 MAIL ADDRESS: STREET 1: C/O EVOFEM BIOSCIENCES, INC. STREET 2: 12400 HIGH BLUFF DRIVE, SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evofem Biosciences, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 550-1900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Neothetics, Inc. DATE OF NAME CHANGE: 20140905 4 1 wf-form4_156200652729907.xml FORM 4 X0306 4 2019-06-30 0 0001618835 Evofem Biosciences, Inc. EVFM 0001360000 Lynch Thomas G C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2019-06-30 4 M 0 37500 0 A 212500 D Restricted Stock Units 2019-06-30 4 M 0 37500 0 D Common Stock 37500.0 112500 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer effective April 1, 2019. The restricted stock units shall vest in four equal installments on June 30, 2019, September 30, 2019, December 31, 2019 and March 31, 2020. /s/ Justin J. File, attorney-in-fact 2019-07-01